Inositol 1,4,5-trisphosphate receptor phosphorylation in breast cancer

Tumor Biology

Volumn 26, Issue 4, 2005, Pages 207-212

  Soghoian, Damien ^a   Jayaraman, Vinodh ^a   Silane, Michael ^c   Berenstein, Alejandro ^c   Jayaraman, Thottala ^a,b,d  

^a ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^b Columbia University ^*  (United States)

^c BETH ISRAEL MEDICAL CENTER   (United States)

^d Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Calcium; Cancer; Cell cycle; Phosphorylation; Signaling

Indexed keywords

CALCIUM ION; CYCLIN DEPENDENT KINASE; CYCLINE; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; CALCIUM CHANNEL; CELL RECEPTOR; ISOPROTEIN; ITPR1 PROTEIN, HUMAN;

ARTICLE; ASSAY; BREAST CANCER; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CANCER CELL; CELL CYCLE; COMPARATIVE STUDY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; BREAST TUMOR; FEMALE; GENE EXPRESSION REGULATION; METABOLISM; POLYACRYLAMIDE GEL ELECTROPHORESIS; TUMOR CELL LINE; WESTERN BLOTTING;

BLOTTING, WESTERN; BREAST NEOPLASMS; CALCIUM CHANNELS; CELL CYCLE; CELL LINE, TUMOR; CYCLINS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOPRECIPITATION; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; PROTEIN ISOFORMS; RECEPTORS, CYTOPLASMIC AND NUCLEAR;

EID: 24644478128     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1159/000086954     Document Type: Article

References (23)

1. Buckley MF, Sweeney KJ, Hamilton JA, Sini RL, Manning DL, Nicholson RI, deFazio A, Watts CK, Musgrove EA, Sutherland RL: Expression and amplification of cyclin genes in human breast cancer. Oncogene 1993;8:2127-2133.
2. Collecchi P, Santoni T, Gnesi E, Giuseppe Naccarato A, Passoni A, Rocchetta M, Danesi R, Bevilacqua G: Cyclins of phases G1, S, and G2/M are overexpressed in aneuploid mammary carcinomas. Cytometry 2000;42:254-260.
3. Bukholm IR, Bukholm G: Over-expression of cyclin A is highly associated with early relapse and reduces survival in patients with primary breast carcinomas. Int J Cancer 2001;93:283-287.
4. Harper JV, Brooks G: The mammalian cell cycle: An overview. Methods Mol Biol 2004;296:113-154.
5. Elledge SJ, Richman R, Hall FL, Williams RT, Lodgson N, Harper JW: CDK2 encodes a 33-kDa cyclin A-associated protein kinase and is expressed before CDC2 in the cell cycle. Proc Natl Acad Sci USA 1992;89:2907-2911.
6. Malathi K, Kohyama S, Ho M, Soghoian D, Li X, Silane M, Berenstein A, Jayaraman T: Inositol 1,4,5-trisphosphate receptor (type 1) phosphorylation and modulation by cdc2. J Cell Biochem 2003;90:1186-1196.
7. Whiteside C, Munk S, Zhou X, Miralem T, Templeton DM: Chelation of intracellular calcium prevents mesangial cell proliferative responsiveness. J Am Soc Nephrol 1998;1046:14-25.
8. Fischer GA, Clementi E, Raichman M, Sudhof T, Ullrich A, Meldolesi J: Stable expression of truncated inositol 1,4,5-trisphosphate receptor subunits in 3T3 fibroblasts. Coordinate signaling changes and differential suppression of cell growth and transformation. J Biol Chem 1994;269:19216-19224.
9. Jayaraman T, Ondriasova E, Ondrias K, Harnick DJ, Marks AR: The inositol 1,4,5-trisphosphate receptor is essential for T-cell receptor signaling. Proc Natl Acad Sci USA 1995;92:6007-6011.
10. Afroze T, Husain M: Cell cycle dependent regulation of intracellular calcium concentration in vascular smooth muscle cells: A potential target for drug therapy. Curr Drug Targets Cardiovasc Haematol Disord 2001;1:23-40.
11. Bruggemann A, Stuhmer W, Pardo LA: Mitosis-promoting factor-mediated suppression of a cloned delayed rectifier potassium channel expressed in Xenopus oocytes. Proc Natl Acad Sci USA 1997;94:537-542.
12. Jayaraman T, Ondrias K, Ondriasova E, Marks AR: Regulation of the inositol 1,4,5-trisphosphate receptor by tyrosine phosphorylation. Science 1996;272:1492-1494.
13. Jayaraman T, Marks AR: Calcineurin is downstream of the inositol 1,4,5-trisphosphate receptor in the apoptotic and cell growth pathways. J Biol Chem 2000;275:6417-6420.
14. Cappelletti V, Fioravanti L, Miodini P, Di Fronzo G: Genistein blocks breast cancer cells in the G(2)M phase of the cell cycle. J Cell Biochem 2000;79:594-600.
15. Keyomarsi K, Sandoval L, Band V, Pardee AB: Synchronization of tumor and normal cells from G1 to multiple cell cycles by lovastatin. Cancer Res 1991;51:3602-3609.
16. Hunter 1995: When is a lipid kinase not a lipid kinase? When it is a protein kinase. Cell 1995;83:1-4.
17. Dynlacht BD, Flores O, Lees JA, Harlow E: Differential regulation of E2F transactivation by cyclin/cdk2 complexes. Genes Dev 1994;8:1772-1786.
18. Adams PD, Sellers WR, Sellers WR, Sharma SK, Wu AD, Nalin CM, Kaelin WG Jr: Identification of a cyclin-cdk2 recognition motif present in substrates and p21-like cyclin-dependent kinase inhibitors. Mol Cell Biol 1996;16:6623-6633.
19. Wohlschlegel JA, Dwyer BT, Takeda DY, Dutta A: Mutational analysis of the Cy motif from p21 reveals sequence degeneracy and specificity for different cyclin-dependent kinases. Mol Cell Biol 2001;21:4868-4874.
20. Russo AA, Jeffrey PD, Patten AK, Massague J, Pavletich NP: Crystal structure of the p27Kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A-Cdk2 complex. Nature 1996;382:325-331.
21. Salicioni AM, Russo IH, Russo J: Correlation between cell cycle regulators and the immortalization and transformation of human breast epithelial cell lines. Int J Oncol 1998;13:65-71.
22. Murakami Y, Tateyama S, Rungsipipat A, Uchida K, Yamaguchi R: Amplification of the cyclin A gene in canine and feline mammary tumors. J Vet Med Sci 2000;62:783-787.
23. Sandhu C, Donovan J, Bhattacharya N, Stampfer M, Worland P, Slingerland J: Reduction of Cdc25A contributes to cyclin E1-Cdk2 inhibition at senescence in human mammary epithelial cells. Oncogene 2000;19:5314-5323.